ArticleEuropean journal of pharmacology2013

Effects of SGLT2 selective inhibitor ipragliflozin on hyperglycemia, hyperlipidemia, hepatic steatosis, oxidative stress, inflammation, and obesity in type 2 diabetic mice.

Atsuo Tahara et al.PubMed ↗Publisher ↗

No numbers read from the abstract.